Cash from Investing (Quarterly) Chart

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2007. Start Trial.
Date Value
June 30, 2026 -0.534M
March 31, 2026 -18.20M
December 31, 2025 -4.73M
September 30, 2025 -0.225M
June 30, 2025 -0.293M
March 31, 2025 -0.212M
December 31, 2024 -37.56M
September 30, 2024 -0.597M
June 30, 2024 5.103M
March 31, 2024 -0.11M
December 31, 2023 -0.203M
September 30, 2023 -20.13M
June 30, 2023 -1.249M
March 31, 2023 -130.97M
December 31, 2022 -0.005M
September 30, 2022 -1.069M
June 30, 2022 -0.259M
March 31, 2022 -0.41M
December 31, 2021 -14.20M
September 30, 2021 -12.93M
June 30, 2021 8.669M
March 31, 2021 -0.224M
December 31, 2020 -0.09M
September 30, 2020 -0.281M
June 30, 2020 -0.337M
Date Value
March 31, 2020 -0.273M
December 31, 2019 -0.969M
September 30, 2019 -0.079M
June 30, 2019 -0.461M
March 31, 2019 -0.324M
December 31, 2018 -0.852M
September 30, 2018 -0.647M
June 30, 2018 -0.436M
March 31, 2018 -0.264M
December 31, 2017 -0.249M
September 30, 2017 -0.197M
June 30, 2017 -0.299M
March 31, 2017 -0.216M
December 31, 2016 -0.114M
September 30, 2016 -1.145M
June 30, 2016 -3.557M
March 31, 2016 -2.423M
December 31, 2015 -0.871M
September 30, 2015 -1.046M
June 30, 2015 -0.18M
March 31, 2015 -3.033M
December 31, 2014 -0.0821M
September 30, 2014 -0.0773M
June 30, 2014 -0.6999M
March 31, 2014 -0.0512M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Viatris, Inc. -51.60M
60 Degrees Pharmaceuticals, Inc. -0.086M
ANI Pharmaceuticals, Inc. -3.054M
Corcept Therapeutics, Inc. -29.24M
Veru, Inc. 1.802M